Thirumalai Chemicals · NSE: TIRUMALCHM · BSE: 500412
Q4 FY26 results · Jan–Mar 2026
Thirumalai Chemicals reported revenue from operations of ₹424.25 crore (down 18.9% from Q4 FY25) and net loss of ₹28.00 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 424.25 | 523.06 | −18.9% | 415.85 | +2.0% |
| Other income | 8.30 | 7.78 | +6.7% | 3.97 | +109.1% |
| Total income | 432.55 | 530.84 | −18.5% | 419.82 | +3.0% |
| Profit before tax | (38.39) | (11.01) | Loss widened | (55.26) | Loss narrowed |
| Net profit for the period | (28.00) | (14.06) | Loss widened | (46.57) | Loss narrowed |
| EPS, basic (₹) | (2.32) | (1.37) | not comparable | (3.92) | Loss narrowed |
| Net margin (%) | -6.6 | -2.7 | -11.2 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 256.95 | 578.21 | −55.6% | 300.27 | −14.4% |
| Other income | 8.61 | 16.46 | −47.7% | 7.20 | +19.6% |
| Total income | 265.56 | 594.67 | −55.3% | 307.47 | −13.6% |
| Profit before tax | (22.86) | 45.02 | Turned loss | (36.09) | Loss narrowed |
| Net profit for the period | (10.83) | 37.51 | Turned loss | (27.42) | Loss narrowed |
| EPS, basic (₹) | (0.90) | 3.66 | not comparable | (2.31) | Loss narrowed |
| Net margin (%) | -4.2 | 6.5 | -9.1 |
Consolidated
- Filed with BSE
- 31 May 2026, 00:01 IST
- Board meeting
- 30 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 May 2026, 00:01 IST
- Board meeting
- 30 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE